Skip to main content

Advertisement

Table 3 Comorbidities of NTM lung disease

From: Characterization of non-tuberculous mycobacterial pulmonary disease in Nanjing district of China

Comorbidities No. of isolates MAB (n = 10) MAV (n = 10) MKA (n = 5) MIN (n = 6) MGO (n = 1) Total87 Percent
Previous TB 8 6 0 41 1 56 64.4%
Clinical Bronchiectasis 6 0 0 11 0 17 19.5%
HIV positive 0 8 4 5 0 17 19.5%
COPD 0 0 1 5 0 6 6.9%
Hepatitis 2 0 0 3 0 5 5.7%
DM 0 0 0 4 0 4 4.6%
Hypertension 1 0 0 3 0 4 4.6%
Cancer 0 0 0 3 0 3 3.4%
AS 0 1 0 0 0 1 1.1%
Pulmonary fibrosis 1 0 0 3 0 4 4.6%
Total 18 15 5 78 1 117  
Percent 15.4% 12.8% 4.3% 66.7% 0.9%   
  1. MAB M. chelonae ss. abscessus and M. chelonae complex, MAV M. avium, MKA M. kansasii, MIN M. intracellulare, MGO M. gordonae. DM diabetes mellitus, COPD chronic obstructive pulmonary disease, AS Ankylosing